Delivery Order SPE2DB22D2206-SPE2DB23FEY72
Award Date 1/3/23
Potential Completion Date 1/4/23
Potential Value $92K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $1,187.55 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division to supply 4,564,361,392 units of the prescription medication Eliquis 2.5 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division to provide 4,565,911,241 Eliquis 5 mg tablets. The fixed-price contract, valued at $3,025.68, has a period of performance through September 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the supply of a wide range of pharmaceutical and medical...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,743.83 contract is for the supply of 60 tablets of the prescription drug Eliquis 5 mg, with a completion date of March 7, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,948.68 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Eliquis 5 mg tablets over the period ending on September 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $16,544.69 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets and has an ultimate completion date of January 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $7,798.56 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Eliquis 5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical worth up to $999,999,999.00, which runs through November 2026. The IDC serves as a primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Eliquis 5 mg tablets. The $19,101.27 firm-fixed-price contract has an ultimate completion date of August 16, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,909.62 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is to supply 4,565,531,240 units of the pharmaceutical product Eliquis 5 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities from...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $37,550.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Eliquis 5 mg tablets. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $15,595.23 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 60-count bottles of Eliquis 5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FEY72Delivery Order
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $92,341.33 to Amerisourcebergen Drug Corp, a division of the pharmaceutical distribution company Cencora, Inc. The contract is for the supply of 4,559,490,389 units of the prescription medication Eliquis 5 mg tablets. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 through December 2025, for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and programs worldwide. The contract does not have a set-aside designation.
Generated 1/10/25, 9:15 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $92.3k | 1/3/23 |